Advocacy intelligence hub — real-time data for patient organizations
Acthrel: FDA approved
To differentiate between pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Acthrel
Ferring Laboratories, Inc.
Acthrel
(Corticorelin ovine triflutate)Orphan drugFerring Laboratories, Inc.
Browse all OBSOLETE: ACTH-independent Cushing syndrome news →
View all OBSOLETE: ACTH-independent Cushing syndrome specialists →